Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05687474
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:27.289720+00:00
Published At
2025-08-12T00:00:00+00:00
Record Updated At
2025-08-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Congenital Adrenal Hyperplasia", "Familial Hyperinsulinemic Hypoglycemia 1", "Phosphoglucomutase 1 Deficiency", "Maturity Onset Diabetes of the Young", "Cystic Fibrosis", "Hypophosphatasia, Infantile", "Congenital Hypothyroidism", "Deficit in Anterior Pituitary Function and Variable Immunodeficiency", "Pituitary Hormone Deficiency, Combined", "Diamond Blackfan Anemia", "Wiskott-Aldrich Syndrome", "Fanconi Anemia", "Hemophilia A", "Hemophilia B", "Glucose 6 Phosphate Dehydrogenase Deficiency", "Alpha-Thalassemia", "Sickle Cell Disease", "Shwachman-Diamond Syndrome", "Alpha 1-Antitrypsin Deficiency", "Inflammatory Bowel Disease 25, Autosomal Recessive", "Wilson Disease", "Progressive Familial Intrahepatic Cholestasis", "Crigler-Najjar Syndrome", "Familial Chylomicronemia", "Lysosomal Acid Lipase Deficiency", "Familial Hemophagocytic Lymphocytosis", "Griscelli Syndrome", "Chediak-Higashi Syndrome", "Severe Congenital Neutropenia", "Severe Combined Immune Deficiency", "Chronic Granulomatous Disease", "Menkes Disease", "Adrenoleukodystrophy", "Smith-Lemli-Opitz Syndrome", "Ataxia With Vitamin E Deficiency", "Thiamine Metabolism Dysfunction Syndrome 5 (Episodic Encephalopathy Type)", "Thiamine Metabolism Dysfunction Syndrome 4 (Bilateral Striatal Degeneration and Progressive Polyneuropathy Type)", "Thiamine-Responsive Megaloblastic Anemia", "Thiamine Metabolism Dysfunction Syndrome 2", "Deficiency of GOT2", "Cerebral Folate Transport Deficiency", "Segawa Syndrome, Autosomal Recessive", "Congenital Myasthenic Syndrome", "Metachromatic Leukodystrophy", "Sepiapterin Reductase Deficiency", "Dopamine Beta Hydroxylase Deficiency", "Glut1 Deficiency Syndrome", "Late-Infantile Neuronal Ceroid Lipofuscinosis", "Aromatic L-amino Acid Decarboxylase Deficiency", "Charcot-Marie-Tooth Disease, Type 6C", "Hereditary Hyperekplexia", "Brain Dopamine-Serotonin Vesicular Transport Disease", "Very Long Chain Hydroxy Acyl Dehydrogenase Deficiency", "Tyrosinemia, Type I", "Disaccharide Intolerance I", "Beta Ketothiolase Deficiency", "Phosphoglycerate Dehydrogenase Deficiency", "Succinyl-Coa:3-Ketoacid Coa-Transferase Deficiency", "Pyridoxine-5\u0027-Phosphate Oxidase Deficiency", "Pyridoxine-Dependent Epilepsy", "Propionic Acidemia", "Pompe Disease", "Phenylalanine Hydroxylase Deficiency", "Ornithine Transcarbamylase Deficiency", "N Acetyl Glutamate Synthetase Deficiency", "Riboflavin Deficiency", "Maple Syrup Urine Disease", "Medium Chain Acyl CoA Dehydrogenase Deficiency", "Malonic Acidemia", "Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency", "Isovaleric Acidemia", "Phosphoserine Aminotransferase Deficiency", "Phosphoserine Phosphatase Deficiency", "Hyperornithinemia-Hyperammonemia-Homocitrullinuria", "S-Adenosylhomocysteine Hydrolase Deficiency", "Mucopolysaccharidosis VII", "Mucopolysaccharidosis VI", "Mucopolysaccharidosis IV A", "Mucopolysaccharidosis II", "Mucopolysaccharidosis I", "Transcobalamin Deficiency", "Isolated Methylmalonic Acidemia", "Cobalamin Deficiency", "Homocystinuria", "Holocarboxylase Synthetase Deficiency", "Fanconi Bickel Syndrome", "Glycogen Storage Disease", "Glycine Encephalopathy", "Glutaric Acidemia I", "Glucose Galactose Malabsorption", "Gaucher Disease, Type 1", "Galactosemias", "Fructosemia", "Fructose-1,6-Diphosphatase Deficiency", "Carbamoyl Phosphate Synthase 1 Deficiency", "Citrullinemia Type II", "Citrullinemia 1", "Creatine Deficiency Syndrome", "Systemic Primary Carnitine Deficiency", "Carnitine Palmitoyltransferase Deficiency 2", "Carnitine Palmitoyltransferase Deficiency 1", "Carnitine Acylcarnitine Translocase Deficiency", "Riboflavin Transporter Deficiency", "Branched-Chain Keto Acid Dehydrogenase Kinase Deficiency", "Andersen Tawil Syndrome", "Timothy Syndrome", "Jervell-Lange Nielsen Syndrome", "Catecholaminergic Polymorphic Ventricular Tachycardia", "Familial Hypertrophic Cardiomyopathy Type 4", "Pseudohypoaldosteronism, Type II", "Pseudohypoaldosteronism Type 1", "Primary Hyperoxaluria", "X Linked Hypophosphatemia", "Hereditary Nephrogenic Diabetes Insipidus", "Cystinosis", "Congenital Nephrotic Syndrome, Finnish Type", "Alport Syndrome", "Hereditary Retinoblastoma", "Biotinidase Deficiency", "Aciduria, Argininosuccinic", "Argininemia", "Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of", "3-Hydroxy 3-Methyl Glutaric Aciduria", "3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-08-12"
protocolSection.identificationModule.nctId
"NCT05687474"
protocolSection.identificationModule.officialTitle
"Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Congenital Adrenal Hyperplasia (protocolSection.conditionsModule.conditions)
  • Familial Hyperinsulinemic Hypoglycemia 1 (protocolSection.conditionsModule.conditions)
  • Phosphoglucomutase 1 Deficiency (protocolSection.conditionsModule.conditions)
  • Maturity Onset Diabetes of the Young (protocolSection.conditionsModule.conditions)
  • Cystic Fibrosis (protocolSection.conditionsModule.conditions)
  • Hypophosphatasia, Infantile (protocolSection.conditionsModule.conditions)
  • Congenital Hypothyroidism (protocolSection.conditionsModule.conditions)
  • Deficit in Anterior Pituitary Function and Variable Immunodeficiency (protocolSection.conditionsModule.conditions)
  • Pituitary Hormone Deficiency, Combined (protocolSection.conditionsModule.conditions)
  • Diamond Blackfan Anemia (protocolSection.conditionsModule.conditions)
  • Wiskott-Aldrich Syndrome (protocolSection.conditionsModule.conditions)
  • Fanconi Anemia (protocolSection.conditionsModule.conditions)
  • Hemophilia A (protocolSection.conditionsModule.conditions)
  • Hemophilia B (protocolSection.conditionsModule.conditions)
  • Glucose 6 Phosphate Dehydrogenase Deficiency (protocolSection.conditionsModule.conditions)
  • Alpha-Thalassemia (protocolSection.conditionsModule.conditions)
  • Sickle Cell Disease (protocolSection.conditionsModule.conditions)
  • Shwachman-Diamond Syndrome (protocolSection.conditionsModule.conditions)
  • Alpha 1-Antitrypsin Deficiency (protocolSection.conditionsModule.conditions)
  • Inflammatory Bowel Disease 25, Autosomal Recessive (protocolSection.conditionsModule.conditions)
  • Wilson Disease (protocolSection.conditionsModule.conditions)
  • Progressive Familial Intrahepatic Cholestasis (protocolSection.conditionsModule.conditions)
  • Crigler-Najjar Syndrome (protocolSection.conditionsModule.conditions)
  • Familial Chylomicronemia (protocolSection.conditionsModule.conditions)
  • Lysosomal Acid Lipase Deficiency (protocolSection.conditionsModule.conditions)
  • Familial Hemophagocytic Lymphocytosis (protocolSection.conditionsModule.conditions)
  • Griscelli Syndrome (protocolSection.conditionsModule.conditions)
  • Chediak-Higashi Syndrome (protocolSection.conditionsModule.conditions)
  • Severe Congenital Neutropenia (protocolSection.conditionsModule.conditions)
  • Severe Combined Immune Deficiency (protocolSection.conditionsModule.conditions)
  • Chronic Granulomatous Disease (protocolSection.conditionsModule.conditions)
  • Menkes Disease (protocolSection.conditionsModule.conditions)
  • Adrenoleukodystrophy (protocolSection.conditionsModule.conditions)
  • Smith-Lemli-Opitz Syndrome (protocolSection.conditionsModule.conditions)
  • Ataxia With Vitamin E Deficiency (protocolSection.conditionsModule.conditions)
  • Thiamine Metabolism Dysfunction Syndrome 5 (Episodic Encephalopathy Type) (protocolSection.conditionsModule.conditions)
  • Thiamine Metabolism Dysfunction Syndrome 4 (Bilateral Striatal Degeneration and Progressive Polyneuropathy Type) (protocolSection.conditionsModule.conditions)
  • Thiamine-Responsive Megaloblastic Anemia (protocolSection.conditionsModule.conditions)
  • Thiamine Metabolism Dysfunction Syndrome 2 (protocolSection.conditionsModule.conditions)
  • Deficiency of GOT2 (protocolSection.conditionsModule.conditions)
  • Cerebral Folate Transport Deficiency (protocolSection.conditionsModule.conditions)
  • Segawa Syndrome, Autosomal Recessive (protocolSection.conditionsModule.conditions)
  • Congenital Myasthenic Syndrome (protocolSection.conditionsModule.conditions)
  • Metachromatic Leukodystrophy (protocolSection.conditionsModule.conditions)
  • Sepiapterin Reductase Deficiency (protocolSection.conditionsModule.conditions)
  • Dopamine Beta Hydroxylase Deficiency (protocolSection.conditionsModule.conditions)
  • Glut1 Deficiency Syndrome (protocolSection.conditionsModule.conditions)
  • Late-Infantile Neuronal Ceroid Lipofuscinosis (protocolSection.conditionsModule.conditions)
  • Aromatic L-amino Acid Decarboxylase Deficiency (protocolSection.conditionsModule.conditions)
  • Charcot-Marie-Tooth Disease, Type 6C (protocolSection.conditionsModule.conditions)
  • Hereditary Hyperekplexia (protocolSection.conditionsModule.conditions)
  • Brain Dopamine-Serotonin Vesicular Transport Disease (protocolSection.conditionsModule.conditions)
  • Very Long Chain Hydroxy Acyl Dehydrogenase Deficiency (protocolSection.conditionsModule.conditions)
  • Tyrosinemia, Type I (protocolSection.conditionsModule.conditions)
  • Disaccharide Intolerance I (protocolSection.conditionsModule.conditions)
  • Beta Ketothiolase Deficiency (protocolSection.conditionsModule.conditions)
  • Phosphoglycerate Dehydrogenase Deficiency (protocolSection.conditionsModule.conditions)
  • Succinyl-Coa:3-Ketoacid Coa-Transferase Deficiency (protocolSection.conditionsModule.conditions)
  • Pyridoxine-5'-Phosphate Oxidase Deficiency (protocolSection.conditionsModule.conditions)
  • Pyridoxine-Dependent Epilepsy (protocolSection.conditionsModule.conditions)
  • Propionic Acidemia (protocolSection.conditionsModule.conditions)
  • Pompe Disease (protocolSection.conditionsModule.conditions)
  • Phenylalanine Hydroxylase Deficiency (protocolSection.conditionsModule.conditions)
  • Ornithine Transcarbamylase Deficiency (protocolSection.conditionsModule.conditions)
  • N Acetyl Glutamate Synthetase Deficiency (protocolSection.conditionsModule.conditions)
  • Riboflavin Deficiency (protocolSection.conditionsModule.conditions)
  • Maple Syrup Urine Disease (protocolSection.conditionsModule.conditions)
  • Medium Chain Acyl CoA Dehydrogenase Deficiency (protocolSection.conditionsModule.conditions)
  • Malonic Acidemia (protocolSection.conditionsModule.conditions)
  • Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency (protocolSection.conditionsModule.conditions)
  • Isovaleric Acidemia (protocolSection.conditionsModule.conditions)
  • Phosphoserine Aminotransferase Deficiency (protocolSection.conditionsModule.conditions)
  • Phosphoserine Phosphatase Deficiency (protocolSection.conditionsModule.conditions)
  • Hyperornithinemia-Hyperammonemia-Homocitrullinuria (protocolSection.conditionsModule.conditions)
  • S-Adenosylhomocysteine Hydrolase Deficiency (protocolSection.conditionsModule.conditions)
  • Mucopolysaccharidosis VII (protocolSection.conditionsModule.conditions)
  • Mucopolysaccharidosis VI (protocolSection.conditionsModule.conditions)
  • Mucopolysaccharidosis IV A (protocolSection.conditionsModule.conditions)
  • Mucopolysaccharidosis II (protocolSection.conditionsModule.conditions)
  • Mucopolysaccharidosis I (protocolSection.conditionsModule.conditions)
  • Transcobalamin Deficiency (protocolSection.conditionsModule.conditions)
  • Isolated Methylmalonic Acidemia (protocolSection.conditionsModule.conditions)
  • Cobalamin Deficiency (protocolSection.conditionsModule.conditions)
  • Homocystinuria (protocolSection.conditionsModule.conditions)
  • Holocarboxylase Synthetase Deficiency (protocolSection.conditionsModule.conditions)
  • Fanconi Bickel Syndrome (protocolSection.conditionsModule.conditions)
  • Glycogen Storage Disease (protocolSection.conditionsModule.conditions)
  • Glycine Encephalopathy (protocolSection.conditionsModule.conditions)
  • Glutaric Acidemia I (protocolSection.conditionsModule.conditions)
  • Glucose Galactose Malabsorption (protocolSection.conditionsModule.conditions)
  • Gaucher Disease, Type 1 (protocolSection.conditionsModule.conditions)
  • Galactosemias (protocolSection.conditionsModule.conditions)
  • Fructosemia (protocolSection.conditionsModule.conditions)
  • Fructose-1,6-Diphosphatase Deficiency (protocolSection.conditionsModule.conditions)
  • Carbamoyl Phosphate Synthase 1 Deficiency (protocolSection.conditionsModule.conditions)
  • Citrullinemia Type II (protocolSection.conditionsModule.conditions)
  • Citrullinemia 1 (protocolSection.conditionsModule.conditions)
  • Creatine Deficiency Syndrome (protocolSection.conditionsModule.conditions)
  • Systemic Primary Carnitine Deficiency (protocolSection.conditionsModule.conditions)
  • Carnitine Palmitoyltransferase Deficiency 2 (protocolSection.conditionsModule.conditions)
  • Carnitine Palmitoyltransferase Deficiency 1 (protocolSection.conditionsModule.conditions)
  • Carnitine Acylcarnitine Translocase Deficiency (protocolSection.conditionsModule.conditions)
  • Riboflavin Transporter Deficiency (protocolSection.conditionsModule.conditions)
  • Branched-Chain Keto Acid Dehydrogenase Kinase Deficiency (protocolSection.conditionsModule.conditions)
  • Andersen Tawil Syndrome (protocolSection.conditionsModule.conditions)
  • Timothy Syndrome (protocolSection.conditionsModule.conditions)
  • Jervell-Lange Nielsen Syndrome (protocolSection.conditionsModule.conditions)
  • Catecholaminergic Polymorphic Ventricular Tachycardia (protocolSection.conditionsModule.conditions)
  • Familial Hypertrophic Cardiomyopathy Type 4 (protocolSection.conditionsModule.conditions)
  • Pseudohypoaldosteronism, Type II (protocolSection.conditionsModule.conditions)
  • Pseudohypoaldosteronism Type 1 (protocolSection.conditionsModule.conditions)
  • Primary Hyperoxaluria (protocolSection.conditionsModule.conditions)
  • X Linked Hypophosphatemia (protocolSection.conditionsModule.conditions)
  • Hereditary Nephrogenic Diabetes Insipidus (protocolSection.conditionsModule.conditions)
  • Cystinosis (protocolSection.conditionsModule.conditions)
  • Congenital Nephrotic Syndrome, Finnish Type (protocolSection.conditionsModule.conditions)
  • Alport Syndrome (protocolSection.conditionsModule.conditions)
  • Hereditary Retinoblastoma (protocolSection.conditionsModule.conditions)
  • Biotinidase Deficiency (protocolSection.conditionsModule.conditions)
  • Aciduria, Argininosuccinic (protocolSection.conditionsModule.conditions)
  • Argininemia (protocolSection.conditionsModule.conditions)
  • Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of (protocolSection.conditionsModule.conditions)
  • 3-Hydroxy 3-Methyl Glutaric Aciduria (protocolSection.conditionsModule.conditions)
  • 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.